Efficacy of SXN in the Treatment of Iron Deficiency Anemia: A Phase IV Clinical Trial

Figure 3

Effective rates of ordinary adults, late gestation women, children, juvenile, elderly, and postoperative patients. The effective rates in the six groups ranged from 79.9% to 91.4%.